225 related articles for article (PubMed ID: 15367562)
1. Localized prostate cancer: quality of life meets Whitmore's legacy.
Bermejo C; Kristal AR; Zeliadt SB; Ramsey S; Thompson IM
J Natl Cancer Inst; 2004 Sep; 96(18):1348-9. PubMed ID: 15367562
[No Abstract] [Full Text] [Related]
2. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.
Pardo Y; Guedea F; Aguiló F; Fernández P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Craven-Bratle J; Suárez JF; Boladeras A; Pont À; Ayala A; Sancho G; Martínez E; Alonso J; Ferrer M
J Clin Oncol; 2010 Nov; 28(31):4687-96. PubMed ID: 20921463
[TBL] [Abstract][Full Text] [Related]
4. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer.
Loeb S; Smith ND; Roehl KA; Catalona WJ
Urology; 2007 Jun; 69(6):1170-5. PubMed ID: 17572209
[TBL] [Abstract][Full Text] [Related]
5. New trial data do not end the PSA screening debate.
Vastag B
J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364
[No Abstract] [Full Text] [Related]
6. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
[TBL] [Abstract][Full Text] [Related]
7. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.
Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R
Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384
[TBL] [Abstract][Full Text] [Related]
8. [Quality of life after localized prostate cancer treatment].
Droupy S
Prog Urol; 2009 Dec; 19 Suppl 4():S163-7. PubMed ID: 20123512
[TBL] [Abstract][Full Text] [Related]
9. Sequential treatment for recurrent localized prostate cancer.
Van Der Poel HG; Moonen L; Horenblas S
J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
[TBL] [Abstract][Full Text] [Related]
10. Further support for active surveillance in the management of low-volume, low-grade prostate cancer.
Albertsen P
Eur Urol; 2010 Dec; 58(6):836-7. PubMed ID: 20851512
[No Abstract] [Full Text] [Related]
11. Obesity adversely affects health related quality of life before and after radical retropubic prostatectomy.
Montgomery JS; Gayed BA; Hollenbeck BK; Daignault S; Sanda MG; Montie JE; Wei JT
J Urol; 2006 Jul; 176(1):257-61; discussion 261-2. PubMed ID: 16753415
[TBL] [Abstract][Full Text] [Related]
12. Local recurrence after primary therapy for clinically localized prostate cancer: is radiation or surgery "Better" in the salvage setting?
Wood CG
J Surg Oncol; 2008 Apr; 97(5):376. PubMed ID: 18360819
[No Abstract] [Full Text] [Related]
13. Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors.
Brooks JP; Albert PS; Wilder RB; Gant DA; McLeod DG; Poggi MM
J Urol; 2005 Dec; 174(6):2204-8, discussion 2208. PubMed ID: 16280764
[TBL] [Abstract][Full Text] [Related]
14. Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation.
Christie D; Denham J; Steigler A; Lamb D; Turner S; Mameghan H; Joseph D; Matthews J; Franklin I; Atkinson C; North J; Poulsen M; Spry NA; Tai KH; Wynne C; Duchesne G; Kovacev O; Francis L; Kramar A; D'Este C; Bill D
Radiother Oncol; 2005 Nov; 77(2):117-25. PubMed ID: 16271786
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer update: 2007.
Lin AM; Small EJ
Curr Opin Oncol; 2008 May; 20(3):294-9. PubMed ID: 18391629
[TBL] [Abstract][Full Text] [Related]
16. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.
Carlucci JR; Nabizada-Pace F; Samadi DB
Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?
King CR
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):1-3. PubMed ID: 21277112
[No Abstract] [Full Text] [Related]
18. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ
J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of clinically localized prostate cancer. Part II--efficiency comparison of therapy methods].
Szelachowska J; Kornafel J; Gisterek I
Pol Merkur Lekarski; 2006 Dec; 21(126):598-601. PubMed ID: 17405306
[TBL] [Abstract][Full Text] [Related]
20. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
